Repare Therapeutics Inc. revenue breakdown overview

Repare Therapeutics Inc. revenue for the last year amounted to 53.48 M USD, the most of which — 53.48 M USD — came from its highest performing source at the moment, Precision Oncology Drugs, the year earlier bringing 51.13 M USD. The greatest contribution to the revenue figure was made by Switzerland — last year it brought Repare Therapeutics Inc. 50.89 M USD, and the year before that — 14.50 M USD.